[Ethacizine in the treatment of psoriasis].
Ethacizine (2-carbethoxyamino-10 (3-diethylaminopropionyl) phenothiazine hydrochloride) has been administered in a daily dose of 150-200 mg for 8-10 weeks to 46 patients with diffuse psoriasis. The treatment has been effective in 84.8% of the patients. Late results, followed up over a year in 40 patients, are fine.
Potekaev
N S
NS
Mazaev
A V
AV
Kurdina
M I
MI
Svet
E A
EA
Kuz'mina
M M
MM
D000293:Adolescent; D000328:Adult; D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D002908:Chronic Disease; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D006321:Heart / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D010640:Phenothiazines / Q000009:adverse effects / Q000627:therapeutic use*; D011565:Psoriasis / Q000188:drug therapy*; D012074:Remission Induction
D000894:Anti-Inflammatory Agents, Non-Steroidal; D010640:Phenothiazines; C046818:ethacizine
Etatsizin v terapii psoriaza.